Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink?

Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare solutions with a market cap of $19.7 billion. Headquartered in Warsaw, Indiana, the company designs, manufactures, and markets a broad portfolio of orthopedic products, including joint reconstruction implants, sports medicine solutions, trauma devices, craniomaxillofacial and thoracic products, and digital and robotic surgical technologies.

The stock has significantly underperformed the broader market over the past year, sliding 18.9%, while the S&P 500 ($SPX) surged 23.5%. The decline has continued into 2025, with ZBH down 5.4% year to date, in contrast to the S&P 500’s 4% gain.